Comments

Valneva Stock Price, Quotes and Forecasts

Q: What sector and industry does Valneva (VALN) operate in?

Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VALNNASDAQ

Logo brought to you by Benzinga Data

Perks Trade with Public

$6.49

At close: Jul 15, 9:28 AM EDT

$6.52

0.030.46%

Pre-Market: Jul 15, 9:28 AM EDT

Valneva (VALN) Forecast

News Earnings Valneva (VALN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Valneva Stock Price, Quotes and Forecasts | NASDAQ:VALN | Benzinga

Explore Valneva stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VALN.

Open	-
Close	-
Volume / Avg.	0 / 35.65K
Day Range	- - -
52 Wk Range	3.62 - 8.66
Market Cap	$554.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	0.04%
Days to Cover	2.07

Recent News

MP Materials, CoreWeave, Trade Desk And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026

Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set for early 2026.

Vandana Singh

US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For Older Adults After Adverse Events

FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including deaths, trigger a new safety assessment.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 35.65K
Day Range	- - -
52 Wk Range	3.62 - 8.66
Market Cap	$554.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	0.04%
Days to Cover	2.07

About Valneva SE

Sector

Health Care

Industry

Biotechnology

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Valneva (VALN) stock?

You can purchase shares of Valneva (NASDAQ:VALN) through any online brokerage.

View our list of the best stock brokerages

Who are Valneva (VALN) competitors?

Other companies in Valneva’s space includes: Precigen (NASDAQ:PGEN), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC), Sage Therapeutics (NASDAQ:SAGE) and Xencor (NASDAQ:XNCR).

What is the forecast, or price target, for Valneva (VALN) stock?

Valneva has a consensus price target of $15.75.

What is the current price for Valneva (VALN)?

The stock price for Valneva (NASDAQ: VALN) is $6.52 last updated July 15, 2025 at 9:28 AM EDT.

Does Valneva (VALN) pay a dividend?

There are no upcoming dividends for Valneva.

When is Valneva (NASDAQ:VALN) reporting earnings?

Valneva’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Valneva (VALN) going to split?

There is no upcoming split for Valneva.

What sector and industry does Valneva (VALN) operate in?

Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.